Tag | Content |
---|
EnhancerAtlas ID | HS176-31114 |
Organism | Homo sapiens |
Tissue/cell | SK-N-SH |
Coordinate | chr5:34524030-34525080 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Nkx2-5(var.2) | MA0503.1 | chr5:34524154-34524165 | CTTGAGTGGTT | - | 6.32 | PRDM1 | MA0508.2 | chr5:34524418-34524428 | GTGAAAGTGA | - | 6.02 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_33763 | chr5:34522735-34525249 | HCC1954 | SE_64200 | chr5:34522920-34524668 | HSMM |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr5 | 34524352 | 34524528 | chr5 | 34524678 | 34524784 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH05I034521 | chr5 | 34521639 | 34525257 |
|
Enhancer Sequence | TTACAAAATA AATGCCTAAG ATGGGGAACA CTCAGCATAT AGTGTTTATA TATATTCACA 60 CACCAAGAAA TAATCAAATA TAATGATGCC AGCATTGATC GTAGATTTTC ATAGCCACAT 120 ATTTCTTGAG TGGTTTGTGC TAGCAAGGGA GACCCAGAGA GTCAGATGCA CTCAAGCTTT 180 TGTAATGAGG TGGTGCAGCA TCTTCAATCC CCAGGGTATC TCCTATAACT TTCTACAGGA 240 TCTGATGCCA TGCTAGAGAG TTGCGAAGCT CTGAATAGCT TTGCTTACAT AGAGTGTTGG 300 GTGTTTTGAG ATTTATTTTG GAAGAGAAAG GAGAGAAGTT TCTCTGAGAC ATAGCAGGTC 360 ATATGTGGCT GAGCCTACAG CAAGGCCAGT GAAAGTGATT ATGAGTCACT CATAGCCTAG 420 GAGTGTGTCC CAACAGATAT TTCTGATTTG GCCCCAGGCC ACCATCAGAC TATGTTGTCT 480 TAAGTTGTCA TATCTGGTAA CTGCAAAAAT AAACCATTTT AGTTGTCATA TAAGATATTG 540 TCATGTAAGT ATTGACCTCT TCAAATGAAT AATCATCTCA AGACCTTCAA ACAAGAAGTG 600 GTTCTAAGGT TGCATATAAG CATTACATAT CGATGAAAAC ATTGATCACA GACATATTAC 660 AGCTGAGTAC CAAGTGCTAC TGGAGTCACA GCAACATCAG TTCTGGATTA TCAATGTTTA 720 TGTCCAAAGG GGAGATAAAT TGTTGACAAG GTAGTAGTCA GGGTAAGTCA ATAGTTCAGT 780 GGGAAAGCAT TAGGGACAGA TCTTTTTAGC TTTACCCTCT TTACCCACCA AACACTCATT 840 TTTAATTAGG AACAGATTCA ATGTGAAGGA TAGGCTCACT CATCACTGTG GTGAGACATT 900 GTTCTCATGT CCTTCACTGC CCACACTCTT TTTATTTTTA TTTTTTTATT TTTTATTTTT 960 TTATGAGACG GAGTCTCGCT CTGTCGCCCA GGCTGGAGTA AAGTGGCACA ATCATGGCTC 1020 ACTGCAGCTA AGACCTCCCC CGGCTCAGGT 1050
|